Carisoprodol

From Ganfyd

Jump to: navigation, search

Contents

Introduction

Withdrawn in EU in November 2007

Clinical Use

Indications

  • Short-term symptomatic relief of muscle spasm

Administration

Oral 350mg tds

Clinical Issues

  • Risk of:
    • Abuse
    • Addiction
    • Intoxication

Contra-indications

Cautions and Interactions

Side effects

  • Drowsiness
  • Psychomotor impairment

Special advice

Pharmacology